Meeting
2021 ASCO Annual Meeting
Predicting response to chemotherapy in neuroblastoma using deep learning: A report from the International Neuroblastoma Risk Group.
Authors
Siddhi Ramesh
University of Chicago Pritzker School of Medicine (Chicago, IL), Chicago, IL
Siddhi Ramesh , Diana Michael , Liu Liu , Nicholas Feinberg , Meaghan Granger , Arlene Naranjo , Susan Lerner Cohn , Samuel Louis Volchenboum , Anoop Mayampurath , Mark A. Applebaum
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10039)
DOI
10.1200/JCO.2021.39.15_suppl.10039
Abstract #
10039
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.
First Author: Keri A. Streby
Poster
2022 ASCO Annual Meeting
Predictors of differential outcomes according to response to induction chemotherapy in high-risk neuroblastoma.
First Author: Elizabeth Sokol
Poster
2020 ASCO Virtual Scientific Program
Outcome in patients with refractory high-risk neuroblastoma.
First Author: Amir Bari Siddiqui
Poster
2018 ASCO Annual Meeting
Gene expression analysis for improved subtyping of high-risk neuroblastoma.
First Author: Jacob Pfeil